Bayer’s NEXAVAR approved in over 70 countries for the treatment of liver cancer (News-Medical-Net)

Bayer Inc. announced today that its international trial known as SHARP (Sorafenib HCC Assessment Randomized Protocol), led by Study Manager and Bayer Canada employee Tom Giannaris, has been selected as the winner in the ‘Best International Trial’ category for the Global Clinical Practice Journal Awards.
(read here…)

Related items

• World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center (News-Medical-Net)
• OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries (News-Medical-Net)
• Alkermes commences ALKS 37 phase 1 clinical trial for the treatment of opioid-induced constipation (News-Medical-Net)
• Biomoda applauds Senator for introducing legislative bill for lung cancer screening (News-Medical-Net)
• Osiris Therapeutics completes enrollment in Prochymal MSC therapy Phase II trial for type 1 diabetes (News-Medical-Net)

Tags: Bayer, bayer canada, bayer inc, cancer, Inc, liver cancer, nano, nanotech, nanotechnology, protocol, SHARP, sorafenib, Technology, today, Tom Giannaris, trial

This entry was posted on Tuesday, November 17th, 2009 at 4:52 pm and is filed under Technology.